Januvia and Plendil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Plendil (felodipine). Common drug interactions include dysphagia among females and haematuria among males.

The phase IV clinical study analyzes what interactions people have when they take Januvia and Plendil. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Plendil?

Plendil has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 4,990 Plendil users. Check the latest studies of Plendil.



On Jul, 27, 2026

49 people who take Januvia and Plendil together, and have interactions are studied.

Januvia and Plendil drug interactions.

What are the common drug interactions of Januvia and Plendil, by gender? *:

female:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Pain
  3. Fall
  4. Abdominal pain upper
  5. Cough
  6. Pain in extremity
  7. Abdominal discomfort
  8. Adverse event
  9. Blindness
  10. Blood glucose decreased

male:

  1. Haematuria (presence of blood in urine)
  2. Oedema peripheral (superficial swelling)
  3. Back pain
  4. Bladder cancer
  5. Bladder mass
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cardiac failure congestive
  8. Cardiomegaly (increased size of heart than normal)
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Carotid artery disease

What are the common drug interactions of Januvia and Plendil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Anxiety
  2. Arrhythmia (irregular heartbeat)
  3. Arterial stenosis (abnormal narrowing of the aortic valve in the heart)
  4. Arthralgia (joint pain)
  5. Arthropathy
  6. Atelectasis (partial or complete collapse of the lung)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Atrophy (wasting away of a part of the body)
  9. Back pain
  10. Bladder cancer

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal injury (kidney injury)
  2. Renal failure (kidney dysfunction)
  3. Adrenal neoplasm (abnormal growth of adrenal gland)
  4. Benign neoplasm of adrenal gland (benign (non-cancerous) tumours of the adrenal gland)
  5. Bladder transitional cell carcinoma (types of bladder cancer)
  6. Chest discomfort
  7. Chronic kidney disease
  8. Haematuria (presence of blood in urine)
  9. Ketoacidosis (high concentrations of ketone bodies in blood)
  10. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)

60+:

  1. Pain
  2. Blood glucose increased
  3. Blood potassium decreased
  4. Blood pressure decreased
  5. Blood sodium decreased
  6. Bone disorder
  7. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  8. Dizziness
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

What are the existing conditions these people have? *

  1. Bone Disorder: 13 people, 26.53%
  2. Multiple Myeloma (cancer of the plasma cells): 10 people, 20.41%
  3. Type 2 Diabetes: 5 people, 10.20%
  4. Prostatic Disorder: 3 people, 6.12%
  5. Indigestion: 3 people, 6.12%
  6. High Blood Cholesterol: 3 people, 6.12%
  7. Heart Rate Irregular: 3 people, 6.12%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.12%
  9. Cardiac Disorder: 3 people, 6.12%
  10. Brain Neoplasm (tumour of brain): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and Plendil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Januvia and Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Plendil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Januvia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Plendil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin phosphate and felodipine (the active ingredients of Januvia and Plendil, respectively), and Januvia and Plendil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: